Recently-developed genome editing tools such as zinc finger nucleases, transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system allow precise manipulation of virtually any gene. All of these editing techniques can be used to introduce double strand breaks at a target DNA sequence that are repaired by the error-prone non-homologous end joining (NHEJ) DNA repair pathway, resulting in introduction of insertion or deletion mutations (INDELs). Detecting these types of induced INDELs at target loci requires a simple and robust method.
- Gene editing product finder
- CRISPR/Cas9 knockouts
- CRISPR/Cas9 knockins
- Genome-wide screening
- Creating and screening for SNPs
- Gene editing tools and information
- CRISPR/Cas9 delivery methods
- Cre recombinase
Comparison of the Guide-it Mutation Detection Kit with a CEL nuclease-based assay
Simple method to identify insertions or deletions in mammalian cells:
Amplify genomic regions directly from cells without the need for DNA purification, and detect mutations with the highly efficient Guide-it Resolvase enzyme
Faster and more efficient than CEL nuclease-based assays:
The Guide-it mutation detection protocol is several hours shorter, more sensitive, and less prone to non-specific cleavage
Mutation detection is often based on PCR amplification of the region of interest and detection of mismatches in heteroduplexed DNA. With the Guide-it Mutation Detection Kit, the target sequence is amplified directly from cells, without genomic DNA extraction/purification (Figure 1, step 1). Then, the PCR products are melted and rehybridized, forming mismatched targets that can be cleaved by the Guide-it Resolvase (Figure 1, steps 2 and 3).
The key component of the Guide-it Mutation Detection Kit is the Guide-it Resolvase, a mismatch-specific nuclease that recognizes heteroduplexed DNA. This enzyme is more efficient and more robust than other similar nucleases, such as Cel1.To compare the Guide-it system and an assay based on CEL nuclease for detecting CRISPR/Cas9-introduced mutations in mammalian cells, 293T cells were transfected with plasmids encoding Cas9 and an sgRNA specific for the AAVS1 locus. Transfected cells harvested 48 hours post-transfection were mixed with untransfected cells at varying ratios (Figure 2, top). A DNA fragment containing the AAVS1 locus was generated by PCR using Terra Direct Polymerase, and the products were purified and cleaved with either Guide-it Resolvase (Guide-it Mutation Detection Kit) or the Cel1 enzyme (Company T). Mutations were easily discernible when using the Guide-it kit (Figure 2, bottom). In contrast, the CEL assay showed considerable smearing, making it difficult to determine cleavage efficiency and reducing the ability to detect lower levels of mutation (Figure 2, bottom).
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2019 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.